Reps. Waxman, Solis, Rangel, Rodriguez, Sherrod Brown, Levin, Linda Sanchez, Allen, McDermott, Grijalva, Becerra, and Stark write the President to express strong opposition to the inclusion of provisions in pending free trade agreements that would restrict access to generic drugs.
Rep. Waxman urges a bipartisan effort to pass legislation that would fully implement the recommendations made by the 9-11 Commission, rather than the deeply flawed House bill, drafted by the Republican leadership, that fully implements just 11 of the 41 recommendations in the Commission's report.
Rep. Waxman asks HHS to revise the proposed Medicare rule that would allow the use of pharmacist-made copies of brand-name prescription drugs to ensure that seniors are not exposed to the serious health risks posed by these non-FDA approved drugs.
Reports prepared by the Special Investigations Division analyze the local impact of the recent record 17% increase in Medicare premiums, the majority of which is directly attributable to provisions contained in the new Medicare law.
On Sept. 29, the House will consider H.R. 3193 -- legislation that would make it legal to carry fully loaded assault weapons and possess armor-piercing ammunition in the nation’s capital city. Members of Congress, the D.C. City Council, and others have spoken out against the measure.
Rep. Waxman, Sen. Kennedy, Sen. Bingaman, and Rep. Solis urge the Centers for Medicare and Medicaid Services to reconsider a proposal that would require hospitals seeking reimbursement to maintain records on the citizenship of patients who are undocumented immigrants.
A series of reports prepared by the Special Investigations Division finds that the prices on prescription drugs offered by the new Medicare drug cards are far higher than discounted prices available in Canada or negotiated by the federal government, and little better than prices already available to seniors through internet pharmacies.
Reps. Waxman, Maloney, and Clay write DOD regarding recent reports that the Department is blocking access to the Federal Voting Assistance Program website for many Americans overseas.
Rep. Waxman releases a report showing that chronic underfunding of the Pell Grant program is increasing the college tuition burden for California's 30th Congressional District.
Data from the Army Field Support Command indicates that more than $7.2 billion has now been committed to Halliburton for troop support in Iraq under the Logistics Civil Augmentation Program (LOGCAP) contract. The records show that between Aug. 3 and Sept. 8 of this year, the obligated value of the company’s Iraq task orders increased by nearly $800 million.
Reps. Waxman and Markey will be introducing legislation to establish a mandatory registry for clinical pharmaceutical drug trials.
Rep. Waxman has released a comprehensive examination of the unprecedented assault on the principle of open government under the Bush Administration.
Senate Democratic Leader Daschle, House Democratic Leader Pelosi, Rep. Waxman, and eleven other congressional leaders renew their request for a congressional investigation into whether the White House authorized the withholding of the Medicare cost estimates from Congress.
Following statements by the President on the need to address our national dependence on foreign oil, Rep. Waxman writes the President to share a recent report that finds that U.S. dependence on foreign sources of oil will worsen under H.R. 6, the energy bill the President supports and is urging Congress to pass.
Rep. Waxman and Chairman Davis write White House Counsel Alberto Gonzales to pass along a recent CRS analysis that indicates there are no legal impediments preventing the White House from taking strong action to ensure that White House officials cooperate with the Justice Department investigation of the leak of a former covert CIA operative’s identity.
In an August 16 memorandum released by Rep. Waxman, the Defense Contract Audit Agency “strongly encourages” the Defense Department to begin withholding 15% of Halliburton’s reimbursements, citing “significant unsupported costs” totaling over $1.8 billion and “numerous, systemic issues” with Halliburton’s cost estimates.
Rep. Waxman, Rep. Brad Carson, and Rep. McCollum request that GAO study the growing problem of sex offenders and prisoners being housed in nursing homes, in some cases resulting in physical and sexual abuse of senior citizens.
Rep. Waxman asks Attorney General Ashcroft to explain why senior officials in the Justice Department overruled the judgment of career prosecutors and authorized the release of detailed information about Sandy Berger requested by Republican congressional staff.
At a Government Reform Committee hearing, Rep. Waxman expressed concerns about the fate of the 9-11 Commission’s recommendations.
A new report from the Inspector General of the Coalition Provisional Authority finds multiple problems in how the United States managed the Iraqi oil proceeds deposited into the Development Fund for Iraq, leading Rep. Waxman to renew his call for a congressional investigation.
In a letter to Chairman Davis, Rep Waxman writes that the Government Reform Committee is applying a different standard to former Clinton-appointee Sandy Berger than it has applied to Bush Administration officials.
Reps. Waxman and Dingell release two reports on Halliburton’s work in Iraq. The first report, prepared by GAO, finds systematic problems in the planning, implementation, and oversight of Halliburton’s contract to provide troop support services. The second report, by the minority staff, finds extensive overcharges in Halliburton’s gasoline prices.
Rep. Waxman, Rep. DeLauro, Sen. Boxer, and Sen. Clinton ask EPA about a recent report that, in developing proposed new regulations concerning "solvent-contaminated industrial wipes," EPA conducted public participation in an inappropriate and one-sided manner.
Rep. Waxman writes HHS to express concern about the pharmaceutical industry’s withholding of the results of clinical trials involving children, despite the extremely valuable six months of exclusive marketing that drug companies are granted in exchange for conducting such studies.
Reps. Waxman, Dingell, Rangel, Stark and Sherrod Brown ask that the acting IG and staff investigators meet with them to discuss the scope, focus, and results of their investigation into the withholding of the Medicare cost estimates.
Displaying Items 826 to 850 of 1318:
[1] • [2] • [3] • [4] • [5] • [6] • [7] • [8] • [9] • [10] • [11] • [12] • [13] • [14] • [15] • [16] • [17] • [18] • [19] • [20] • [21] • [22] • [23] • [24] • [25] • [26] • [27] • [28] • [29] • [30] • [31] • [32] • [33] • [34] • [35] • [36] • [37] • [38] • [39] • [40] • [41] • [42] • [43] • [44] • [45] • [46] • [47] • [48] • [49] • [50] • [51] • [52] • [53]